COVID-19 Therapeutics Transition to Commercial Distribution Frequently Asked Questions

Administration for Strategic Preparedness and Response. (2023). COVID-19 Therapeutics Transition to Commercial Distribution: Frequently Asked Questions. U.S. Department of Health and Human Services.
This webpage provides answers to frequently asked questions about commercial distribution.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.